Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jarunya Narangajavana
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Alleviates Salinity Stress in Cassava
Frontiers in Plant Science
Plant Science
Related publications
The Role of Oxidative Stress in Apoptosis Induced by the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Human Colon Adenocarcinoma HT-29 Cells
International Journal of Oncology
Cancer Research
Oncology
The Proteasome Inhibitor Bortezomib Interacts Synergistically With the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid to Induce T-Leukemia/Lymphoma Cells Apoptosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Suberoylanilide Hydroxamic Acid (SAHA)-Induced Dynamics of a Human Histone Deacetylase Protein Interaction Network
Molecular and Cellular Proteomics
Biochemistry
Medicine
Analytical Chemistry
Molecular Biology
Synergistic Effects of Combined Treatment With Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and TRAIL on Human Breast Cancer Cells
Scientific Reports
Multidisciplinary
Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer in Vitro and in Vivo
PLoS ONE
Multidisciplinary
The Histone Deacetylase Inhibitor and Chemotherapeutic Agent Suberoylanilide Hydroxamic Acid (SAHA) Induces a Cell-Death Pathway Characterized by Cleavage of Bid and Production of Reactive Oxygen Species
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Pharmacokinetics and Pharmacodynamics of Suberoylanilide Hydroxamic Acid in Cats
Journal of Veterinary Pharmacology and Therapeutics
Veterinary
Pharmacology
A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients With Refractory Hematologic Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro
Oncology Letters
Cancer Research
Oncology